Home

repertoara Jugoistok ego doi 10.1093 ecco jcc jjx009 Sijati Razoružanje Pozdrav

Frontiers | Natural Anti-Inflammatory Compounds as Drug Candidates for  Inflammatory Bowel Disease
Frontiers | Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease

Full article: New treatment strategies for ulcerative colitis
Full article: New treatment strategies for ulcerative colitis

Low adherence to treatment is a weak link in the problems of ulcerative  colitis - Parfenov - Terapevticheskii arkhiv
Low adherence to treatment is a weak link in the problems of ulcerative colitis - Parfenov - Terapevticheskii arkhiv

Constipation in ulcerative colitis: pathophysiology and practical  management | Frontline Gastroenterology
Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology

The influence of cytokines on the complex pathology of ulcerative colitis -  ScienceDirect
The influence of cytokines on the complex pathology of ulcerative colitis - ScienceDirect

Steroid Resistance/Dependence Might Be an Alarming Feature for  Cytomegalovirus Infection Among Ulcerative Colitis Patients With
Steroid Resistance/Dependence Might Be an Alarming Feature for Cytomegalovirus Infection Among Ulcerative Colitis Patients With

Real-world disease activity and sociodemographic, clinical and treatment  characteristics of moderate-to-severe inflammatory bowe
Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowe

Infliximab formulation strategy for a stable ileo-colonic targeted oral  dosage form intended for the topical treatment of inflammatory bowel  disease - ScienceDirect
Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect

Treatment patterns among patients with moderate-to-severe ulcerative  colitis in the United States and Europe
Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe

Mucosal gene expression in inflammatory bowel disease | CEG
Mucosal gene expression in inflammatory bowel disease | CEG

Ulcerative Colitis and Pregnancy | IntechOpen
Ulcerative Colitis and Pregnancy | IntechOpen

Living with Ulcerative Colitis Study (LUCY) in England: a retrospective  study evaluating healthcare resource utilisation and direct healthcare  costs of postoperative care in ulcerative colitis | BMJ Open  Gastroenterology
Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology

PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal  Inflammation and Disease Activity in Ulcerative Colitis
PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis

Effectiveness and safety of vedolizumab in a matched cohort of elderly and  nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study  - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online  Library
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library

2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two  Parts - Page 11 of 11 - Tom Wade MD
2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 11 of 11 - Tom Wade MD

Inflammatory Indexes for Assessing the Severity and Disease Progression of  Ulcerative Colitis: A Single-Center Retrospective Study - Frontiers
Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study - Frontiers

Frontiers | Management of Non-response and Loss of Response to Anti-tumor  Necrosis Factor Therapy in Inflammatory Bowel Disease
Frontiers | Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in  Ulcerative Colitis: Can Their Availability Change According to Treatment  Options?
Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options?

Ulcerative Colitis and Pregnancy | IntechOpen
Ulcerative Colitis and Pregnancy | IntechOpen

Real world practice of medical treatment for moderate and severe  inflammatory bowel diseases in Russian Federation, Republic of Belarus and  Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -

Real world practice of medical treatment for moderate and severe  inflammatory bowel diseases in Russian Federation, Republic of Belarus and  Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -

Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challeng | CEG
Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challeng | CEG

Megacolon tossico e colite pseudomembranosa Megacolon tossico e colite  pseudomembranosa
Megacolon tossico e colite pseudomembranosa Megacolon tossico e colite pseudomembranosa

Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric  Inflammatory Bowel Disease—A Review of the Evidence
Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence